Ling Yu

2.0k total citations
54 papers, 1.6k citations indexed

About

Ling Yu is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ling Yu has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ling Yu's work include Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (6 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). Ling Yu is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (6 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). Ling Yu collaborates with scholars based in China, United States and Australia. Ling Yu's co-authors include Wayne A. Border, Yufeng Huang, Nancy A. Noble, Daniel A. Lawrence, David J. McQuillan, Masashi Haraguchi, Yiling Ding, Han Li, Shixiang Wang and Qun Xu and has published in prestigious journals such as Journal of Clinical Investigation, International Journal of Molecular Sciences and Kidney International.

In The Last Decade

Ling Yu

53 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Yu China 20 420 420 404 304 217 54 1.6k
Naifeng Liu China 27 657 1.6× 495 1.2× 301 0.7× 304 1.0× 349 1.6× 83 2.1k
Wei Cao China 21 602 1.4× 294 0.7× 263 0.7× 186 0.6× 146 0.7× 70 1.6k
Jérémy Bellien France 23 388 0.9× 630 1.5× 224 0.6× 349 1.1× 210 1.0× 76 1.9k
Hisashi Makino Japan 27 634 1.5× 509 1.2× 308 0.8× 417 1.4× 165 0.8× 63 1.9k
Yusuke Nakagawa Japan 21 501 1.2× 573 1.4× 191 0.5× 272 0.9× 149 0.7× 86 1.7k
Marie‐Paule Wautier France 22 582 1.4× 183 0.4× 297 0.7× 529 1.7× 247 1.1× 36 2.5k
Isabelle Six France 22 617 1.5× 524 1.2× 461 1.1× 128 0.4× 195 0.9× 48 2.2k
Giovanni M. Puddu Italy 21 415 1.0× 386 0.9× 193 0.5× 160 0.5× 175 0.8× 54 1.6k
Evren Caglayan Germany 24 502 1.2× 507 1.2× 153 0.4× 141 0.5× 285 1.3× 62 1.7k
Maki Urushihara Japan 29 590 1.4× 1.0k 2.4× 631 1.6× 699 2.3× 206 0.9× 81 2.5k

Countries citing papers authored by Ling Yu

Since Specialization
Citations

This map shows the geographic impact of Ling Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Yu more than expected).

Fields of papers citing papers by Ling Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Yu. The network helps show where Ling Yu may publish in the future.

Co-authorship network of co-authors of Ling Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Yu. A scholar is included among the top collaborators of Ling Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Yu. Ling Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Juan, et al.. (2024). A comparative analysis of three frailty assessment tools for hospitalized patients with stroke. Clinical Neurology and Neurosurgery. 246. 108600–108600. 2 indexed citations
2.
Wang, Honglin, Wenjing Luo, Na Li, et al.. (2023). Knowledge, attitudes, and practice of Endocrinology healthcare workers regarding screening for pre-ulcerative diabetic foot lesions. Journal of Tissue Viability. 32(4). 472–479. 5 indexed citations
3.
4.
Du, Jing, Hong Zhu, Ling Yu, et al.. (2021). Multi-Dimensional Diffusion Tensor Imaging Biomarkers for Cognitive Decline From the Preclinical Stage: A Study of Post-stroke Small Vessel Disease. Frontiers in Neurology. 12. 687959–687959. 15 indexed citations
5.
6.
Yu, Ling, et al.. (2021). In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis. Frontiers in Bioengineering and Biotechnology. 8. 613784–613784. 7 indexed citations
7.
Du, Jing, Hong Zhu, Jie Zhou, et al.. (2020). Structural Brain Network Disruption at Preclinical Stage of Cognitive Impairment Due to Cerebral Small Vessel Disease. Neuroscience. 449. 99–115. 25 indexed citations
8.
Yu, Ling, et al.. (2019). Association between Serum Magnesium and Erythropoietin Responsiveness in Hemodialysis Patients: A Cross-Sectional Study. Kidney & Blood Pressure Research. 44(3). 354–361. 11 indexed citations
9.
Yu, Ling, et al.. (2018). Circulating α-Klotho Levels in Hemodialysis Patients and Their Relationship to Atherosclerosis. Kidney & Blood Pressure Research. 43(4). 1174–1182. 24 indexed citations
10.
11.
Wang, Jinglei, et al.. (2017). Application of 3D-HyCoSy in the diagnosis of oviduct obstruction. Experimental and Therapeutic Medicine. 13(3). 966–970. 5 indexed citations
12.
Yu, Ling, Han Li, & Shixiang Wang. (2016). Serum Magnesium and Mortality in Maintenance Hemodialysis Patients. Blood Purification. 43(1-3). 31–36. 34 indexed citations
13.
Yu, Ling. (2014). Clinical study of sinomenine combined with methotrexate on the repair of bone destruction in rheumatoid arthritis. 2 indexed citations
14.
Wu, Ting, Haiyan Chu, Wenzhen Tu, et al.. (2014). Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis. BMC Complementary and Alternative Medicine. 14(1). 224–224. 25 indexed citations
15.
Zhang, Xiaowen, et al.. (2014). Human leukocyte antigen G and miR-148a are associated with the pathogenesis of intrahepatic cholestasis of pregnancy. Experimental and Therapeutic Medicine. 8(6). 1701–1706. 12 indexed citations
16.
Huang, Yufeng, Wayne A. Border, Ling Yu, et al.. (2008). A PAI-1 Mutant, PAI-1R, Slows Progression of Diabetic Nephropathy. Journal of the American Society of Nephrology. 19(2). 329–338. 75 indexed citations
17.
Wang, Haiyan, Jingzi Li, Ling Yu, Yani Zhao, & Wei Ding. (2003). Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis. Life Sciences. 74(13). 1645–1658. 51 indexed citations
18.
Huang, Yufeng, Masashi Haraguchi, Daniel A. Lawrence, et al.. (2003). A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. Journal of Clinical Investigation. 112(3). 379–388. 115 indexed citations
19.
20.
Zhou, Chun, et al.. (1999). Renal Protective Effects of Blocking the Intrarenal Renin-Angiotensin System.. Hypertension Research. 22(3). 223–228. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naifeng Liu Breakdown of academic impact, for papers by Wei Cao Breakdown of academic impact, for papers by Jérémy Bellien Breakdown of academic impact, for papers by Hisashi Makino Breakdown of academic impact, for papers by Yusuke Nakagawa Breakdown of academic impact, for papers by Marie‐Paule Wautier Breakdown of academic impact, for papers by Isabelle Six Breakdown of academic impact, for papers by Giovanni M. Puddu Breakdown of academic impact, for papers by Evren Caglayan Breakdown of academic impact, for papers by Maki Urushihara
Rankless by CCL
2026